Last reviewed · How we verify
NCT06063161
Music Therapy to Prevent Hospital-acquired Delirium in Parkinson's Disease and Dementia With Lewy Bodies
NA trial testing Music therapy intervention in Parkinson Disease in 30 participants. Completed in 1 November 2025.
1 July 2025
Quick facts
| Lead sponsor | University of Massachusetts, Worcester |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 April 2024 |
| Primary completion | 1 July 2025 |
| Estimated completion | 1 November 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Music therapy intervention
- Standard Care (in control arm) — full drug profile →
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Dementia, Lewy Body — all drugs for Dementia, Lewy Body →
- Delirium — all drugs for Delirium →
Sponsor
University of Massachusetts, Worcester
Who can join
60 and older, any sex, with Parkinson Disease or Dementia, Lewy Body. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to test whether a music therapy intervention (MT) prevents hospital-acquired delirium (HaD) in patients with Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB). Delirium is defined as a mental state in which you are confused, disoriented, and not able to think or remember clearly. It can start suddenly and is usually temporary. It is common among patients with PD/DLB during hospitalization. We are conducting a randomized controlled feasibility pilot study of music therapy (MT) in patients with PD/DLB in the inpatient acute hospital setting. We are testing if receiving music therapy lowers the risk of delirium, compared to other interventions. We are also testing if music therapy lowers the need for certain restraints and medications during the hospitalization. Participants admitted to UMass Memorial Medical Center will be invited to participate. Participants will be asked to undergo a music therapy intervention for 30 minutes 3 times per week, and to listen to personalized music playlists for 60 minutes 4 times per week. Participants will be assessed for HaD every 24 hours, and will undergo additional surveys and questionnaires. Researchers will compare the music therapy intervention to two another comparison groups: one group assigned to listen to music on their own, and one group assigned to receive only standard treatments. About one-third of the participants will be assigned to each of the three study groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06063161
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Music therapy intervention
Trials testing the same drug.
- NCT07235098 — Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surge · NA · not yet recruiting
- NCT06939426 — Music Therapy and Humanization in ED Healthcare Professionals · NA · recruiting
- NCT05508646 — Group-Based Telehealth Music Therapy Intervention for Patients With Dementia: A Pilot Study · NA · completed
- NCT04446624 — Oxidative Stress, Anxiety and Depression in Breast Cancer Patients: Impact of Music Therapy · NA · completed
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other University of Massachusetts, Worcester trials
Trials by the same sponsor.
- NCT07431528 — Dementia and Storytelling in Vietnam · NA · not yet recruiting
- NCT07060664 — Study on Outcomes of Proximal Humerus Fractures · NA · not yet recruiting
- NCT07520110 — Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis · Phase 3 · not yet recruiting
- NCT06100809 — Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts · NA · not yet recruiting
- NCT06246539 — Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06063161 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Worcester
- Last refreshed: 13 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06063161.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing